[1]
M. H. L. da Silva, T. M. S. Silva, B. J. M. da Silva, B. G. Pinheiro, and T. V. G. Alves, “EPIDEMIOLOGICAL AND CLINICAL PROFILE OF NOTIFICATIONS RELATED TO ADVERSE EVENTS TO BOTULINUM TOXIN IN BRAZIL: AN ANALYSIS OF DATA FROM VIGIMED (2018–2025)”, REASE, vol. 12, no. 3, pp. 1–11, Mar. 2026, doi: 10.51891/rease.v12i3.24539.